ARK Genomic Revolution UCITS ETF USD Accumulating

ISIN IE000O5M6XO1

TER
0,75% p.a.
Distributiebeleid
Accumulerend
Replicatie
Volledige replicatie
Fondsgrootte
5 m
Bedrijven
37
 

Overzicht

Verhandel deze ETF bij je broker

Kies uw broker

Beschrijving

De ARK Genomic Revolution UCITS ETF USD Accumulating is een actief beheerde ETF.
The ETF invests in companies from around the world that are expected to derive revenue from technological innovations in the genomic healthcare sector. The stocks included are filtered according to ESG criteria (environmental, social and corporate governance).
 
The ETF's TER (total expense ratio) amounts to 0,75% p.a.. The ARK Genomic Revolution UCITS ETF USD Accumulating is the only ETF that tracks the ARK Genomic Revolution index. The ETF replicates the performance of the underlying index by full replication (buying all the index constituents). The dividends in the ETF are accumulated and reinvested in the ETF.
 
The ARK Genomic Revolution UCITS ETF USD Accumulating is a very small ETF with 5m Euro assets under management. The ETF was launched on 12 april 2024 and is domiciled in Ierland.
Toon meer Toon minder
Actief beheerde strategie

Grafiek

Basis

Data

Index
ARK Genomic Revolution
Investeringsfocus
Aandelen, Wereld, Gezondheidszorg
Fondsgrootte
EUR 5 m
Totale kostenratio (TER)
0,75% p.a.
Replicatie Fysiek (Volledige replicatie)
Juridische structuur ETF
Strategierisico Actief beheerd
Duurzaamheid Yes
Valuta van het fonds USD
Valutarisico Valuta niet gedekt
Volatiliteit 1 jaar (in EUR)
-
Oprichtingsdatum/Noteringsdatum 12 april 2024
Distributiebeleid Accumulerend
Distributiefrequentie -
Vestigingsplaats van het fonds Ierland
Fondsaanbieder ARK Invest International
Duitsland 30% belastingvermindering
Zwitserland ESTV Reporting
Oostenrijk Belastingrapportagefonds
UK UK-rapportage
Indextype -
Swap tegenpartij -
Collateral manager
Effectenlening No
Tegenpartij die effecten uitleent

Vergelijkbare ETF

In dit gedeelte vind je informatie over andere ETF met een vergelijkbare beleggingsfocus als de ARK Genomic Revolution UCITS ETF USD Accumulating
Vergelijkbare ETF via ETF zoeken
Wat vind je van ons ETF-profiel? Here you'll find our Questionnaire.

Bedrijven

Hieronder vind je informatie over de samenstelling van de ARK Genomic Revolution UCITS ETF USD Accumulating

Top 10 holdings

Weging van top 10-holdings
van 37
52,78%
Twist Bioscience
8,27%
CRISPR Therapeutics
7,15%
Recursion Pharmaceuticals
6,82%
CareDx
5,15%
Veracyte
4,53%
Ionis Pharmaceuticals
4,38%
Adaptive Biotechnologies
4,36%
Nurix Therapeutics
4,28%
Natera
4,07%
Intellia Therapeutics
3,77%

Landen

Verenigde Staten
87,23%
Zwitserland
7,15%
Anders
5,62%

Sectoren

Gezondheidszorg
95,24%
Technologie
0,85%
Anders
3,91%
Vanaf 30/10/2024

Beleggingsplanaanbiedingen

Hier vind je informatie over de beschikbaarheid van het beleggingsplan van de ETF. Je kunt de tabel gebruiken om alle beleggingsplanaanbiedingen voor de geselecteerde spaarrente te vergelijken.
 
Broker Rating Kosten beleggingsplan Kosten brokeraccount
0,00€
0,00€
Bekijk het aanbod*
Bron: justETF Research; Vanaf 12/2024; *Affiliate link
— De aanbiedingen zijn als volgt gesorteerd: 1. Rating 2. Kosten beleggingsplan 3. Aantal ETF-beleggingsplannen.
— Er kan geen garantie worden gegeven voor de volledigheid en juistheid van de vermelde informatie. De informatie van de online brokers is doorslaggevend. Naast de aangegeven makelaarskosten kunnen extra kosten (bijv. spreads, fooien en productkosten) van toepassing zijn.

Prestaties

Rendementsoverzicht

YTD -
1 maand +5,80%
3 maanden +12,86%
6 maanden +7,97%
1 jaar -
3 jaar -
5 jaar -
Since inception +4,87%
2023 -
2022 -
2021 -
2020 -

Maandelijks rendement in een heat map

Risico

Risk metrics in this section:
 
  • Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
  • Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
  • Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
ETF-rendementen zijn inclusief dividenduitkeringen (indien van toepassing).
Toon meer Toon minder

Risico-overzicht

Volatiliteit 1 jaar -
Volatiliteit 3 jaar -
Volatiliteit 5 jaar -
Rendement/Risico 1 jaar -
Rendement/Risico 3 jaar -
Rendement/Risico 5 jaar -
Maximaal waardedaling 1 jaar -
Maximaal waardedaling 3 jaar -
Maximaal waardedaling 5 jaar -
Maximaal waardedaling sinds aanvang -15,64%

Voortschrijdende volatiliteit over 1 jaar

Beurs

Beursnoteringen

Beursnotering Handelsvaluta Ticker Bloomberg /
iNAV Bloomberg Code
Reuters RIC /
iNAV Reuters
Market Maker
gettex EUR AAKG -
-
-
-
-
Borsa Italiana EUR ARKG -
-
-
-
-
London Stock Exchange GBX ARCG

London Stock Exchange USD ARKG

SIX Swiss Exchange CHF ARKG

Xetra EUR AAKG

Meer informatie

Andere ETF met vergelijkbare beleggingsfocus

Naam fonds Fondsgrootte in €m (AuM) TER p.j. Distributie Replicatiemethode
iShares Healthcare Innovation UCITS ETF 1.014 0,40% p.a. Accumulerend Sampling
L&G Healthcare Breakthrough UCITS ETF USD Acc 66 0,49% p.a. Accumulerend Volledige replicatie
L&G Pharma Breakthrough UCITS ETF 18 0,49% p.a. Accumulerend Volledige replicatie
Harbor Health Care UCITS ETF Accumulating 15 0,89% p.a. Accumulerend Volledige replicatie
VanEck Genomics and Healthcare Innovators UCITS ETF A 5 0,35% p.a. Accumulerend Volledige replicatie

Veelgestelde vragen

What is the name of -?

The name of - is ARK Genomic Revolution UCITS ETF USD Accumulating.

What is the ticker of ARK Genomic Revolution UCITS ETF USD Accumulating?

The primary ticker of ARK Genomic Revolution UCITS ETF USD Accumulating is -.

What is the ISIN of ARK Genomic Revolution UCITS ETF USD Accumulating?

The ISIN of ARK Genomic Revolution UCITS ETF USD Accumulating is IE000O5M6XO1.

What are the costs of ARK Genomic Revolution UCITS ETF USD Accumulating?

The total expense ratio (TER) of ARK Genomic Revolution UCITS ETF USD Accumulating amounts to 0,75% p.a.. These costs are withdrawn continuously from the fund assets and already included in the performance of the ETF. You don't have to pay them separately. Please have a look at our article for more information about the cost of ETFs.

Is ARK Genomic Revolution UCITS ETF USD Accumulating paying dividends?

ARK Genomic Revolution UCITS ETF USD Accumulating is an accumulating ETF. This means that dividends are not distributed to investors. Instead, dividends are reinvested in the fund on the ex-date, which leads to an increase of the ETF's share price.

What's the fund size of ARK Genomic Revolution UCITS ETF USD Accumulating?

The fund size of ARK Genomic Revolution UCITS ETF USD Accumulating is 5m Euro. See the following article for more information about the size of ETFs.

Track your ETF strategies online

— Gegevens verstrekt door Trackinsight, etfinfo, Xignite Inc., gettex, FactSet en justETF GmbH.

Standaard zijn ETF-rendementen inclusief dividenduitkeringen (indien van toepassing).